$PED
PEDEVCO CORP

2023 Q1 Form 10-K Financial Statement

#000165495423003759 Filed on March 29, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $8.164M $5.925M $30.03M
YoY Change 15.15% 31.08% 89.37%
Cost Of Revenue $2.466M $2.321M $10.40M
YoY Change 4.67% 30.47% 74.95%
Gross Profit $5.698M $3.604M $19.64M
YoY Change 20.36% 31.48% 98.01%
Gross Profit Margin 69.79% 60.83% 65.38%
Selling, General & Admin $1.488M $1.746M $5.854M
YoY Change -6.53% -1.63% -5.72%
% of Gross Profit 26.11% 48.45% 29.81%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.581M $4.726M $11.15M
YoY Change 36.85% 85.26% 51.12%
% of Gross Profit 45.3% 131.13% 56.8%
Operating Expenses $6.535M $6.472M $27.40M
YoY Change 12.02% 49.61% 40.3%
Operating Profit $1.629M -$2.868M $2.630M
YoY Change 29.7% 80.95% -240.87%
Interest Expense $98.00K $77.00K $0.00
YoY Change 1825.0% -100.0%
% of Operating Profit 6.02% 0.0%
Other Income/Expense, Net $133.0K $7.000K $214.0K
YoY Change 60.24% -93.27% -62.32%
Pretax Income $1.762M -$2.784M $2.844M
YoY Change 31.59% 88.49% -318.94%
Income Tax
% Of Pretax Income
Net Earnings $1.762M -$2.784M $2.844M
YoY Change 31.59% 88.49% -318.94%
Net Earnings / Revenue 21.58% -46.99% 9.47%
Basic Earnings Per Share $0.02 $0.03
Diluted Earnings Per Share $0.02 -$0.03 $0.03
COMMON SHARES
Basic Shares Outstanding 87.04M shares 85.79M shares 85.51M shares
Diluted Shares Outstanding 86.72M shares 85.51M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.14M $29.43M $29.43M
YoY Change -35.25% 13.5% 13.5%
Cash & Equivalents $14.14M $29.43M
Short-Term Investments
Other Short-Term Assets $149.0K $249.0K $249.0K
YoY Change -31.34% -23.62% -23.62%
Inventory
Prepaid Expenses
Receivables $5.788M $2.430M $2.430M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $20.08M $32.11M $32.11M
YoY Change -22.86% 14.52% 14.52%
LONG-TERM ASSETS
Property, Plant & Equipment $84.24M $80.22M $80.22M
YoY Change 17.27% 20.38% 20.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.821M $3.783M $3.783M
YoY Change 8.15% 6.77% 6.77%
Total Long-Term Assets $88.06M $84.00M $84.00M
YoY Change 16.84% 19.69% 19.69%
TOTAL ASSETS
Total Short-Term Assets $20.08M $32.11M $32.11M
Total Long-Term Assets $88.06M $84.00M $84.00M
Total Assets $108.1M $116.1M $116.1M
YoY Change 6.65% 18.21% 18.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.683M $1.556M $1.556M
YoY Change -6.83% -40.75% -40.75%
Accrued Expenses $1.375M $13.84M $13.92M
YoY Change 3.62% 851.51% 787.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.767M $16.96M $16.96M
YoY Change 7.62% 227.39% 227.39%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.628M $2.689M $2.689M
YoY Change 53.15% 72.7% 72.7%
Total Long-Term Liabilities $2.628M $2.689M $2.689M
YoY Change 53.15% 72.7% 72.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.767M $16.96M $16.96M
Total Long-Term Liabilities $2.628M $2.689M $2.689M
Total Liabilities $9.395M $19.65M $19.65M
YoY Change 17.38% 191.64% 191.64%
SHAREHOLDERS EQUITY
Retained Earnings -$125.0M -$126.7M
YoY Change -2.19%
Common Stock $87.00K $86.00K
YoY Change 2.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $98.74M $96.46M $96.46M
YoY Change
Total Liabilities & Shareholders Equity $108.1M $116.1M $116.1M
YoY Change 6.65% 18.21% 18.21%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $1.762M -$2.784M $2.844M
YoY Change 31.59% 88.49% -318.94%
Depreciation, Depletion And Amortization $2.581M $4.726M $11.15M
YoY Change 36.85% 85.26% 51.12%
Cash From Operating Activities $1.782M $2.987M $15.98M
YoY Change 25.94% 49.42% 167.69%
INVESTING ACTIVITIES
Capital Expenditures $17.07M $839.0K $12.25M
YoY Change -409.97% -134.22% -364.51%
Acquisitions
YoY Change
Other Investing Activities -$14.00K -$14.00K
YoY Change -100.75%
Cash From Investing Activities -$17.07M -$853.0K -$12.27M
YoY Change 209.97% -65.21% 344.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $35.00K
YoY Change -99.76%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -15.00K $35.00K
YoY Change -100.23% -99.76%
NET CHANGE
Cash From Operating Activities $1.782M 2.987M $15.98M
Cash From Investing Activities -$17.07M -853.0K -$12.27M
Cash From Financing Activities -15.00K $35.00K
Net Change In Cash -$15.29M 2.119M $3.750M
YoY Change 273.59% -64.71% -79.05%
FREE CASH FLOW
Cash From Operating Activities $1.782M $2.987M $15.98M
Capital Expenditures $17.07M $839.0K $12.25M
Free Cash Flow -$15.29M $2.148M $3.729M
YoY Change -320.87% -51.74% -64.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001141197
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
85790267 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
84236146 shares
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-858000 usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-35922
CY2022 dei Entity Registrant Name
EntityRegistrantName
PEDEVCO Corp.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
TX
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
22-3755993
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
575 N. Dairy Ashford
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 210
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77079
CY2022 dei City Area Code
CityAreaCode
713
CY2022 dei Local Phone Number
LocalPhoneNumber
221-1768
CY2022 dei Security12b Title
Security12bTitle
Common Stock,$0.001 Par Value Per Share
CY2022 dei Trading Symbol
TradingSymbol
PED
CY2022 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
30856734 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
87040267 shares
CY2022 dei Auditor Name
AuditorName
Marcum LLP
CY2022 dei Auditor Location
AuditorLocation
Houston, Texas
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29430000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25930000 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
2430000 usd
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1782000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
249000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
326000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
32109000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
28038000 usd
CY2022Q4 us-gaap Oil And Gas Property Full Cost Method Gross
OilAndGasPropertyFullCostMethodGross
79372000 usd
CY2021Q4 us-gaap Oil And Gas Property Full Cost Method Gross
OilAndGasPropertyFullCostMethodGross
63908000 usd
CY2022Q4 ped Oil And Gas Properties Not Subject To Amortization Net
OilAndGasPropertiesNotSubjectToAmortizationNet
775000 usd
CY2021Q4 ped Oil And Gas Properties Not Subject To Amortization Net
OilAndGasPropertiesNotSubjectToAmortizationNet
2559000 usd
CY2022Q4 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
80147000 usd
CY2021Q4 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
66467000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
71000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
173000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3783000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3543000 usd
CY2022Q4 us-gaap Assets
Assets
116110000 usd
CY2021Q4 us-gaap Assets
Assets
98221000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1556000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2626000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13835000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1454000 usd
CY2022Q4 ped Revenue Payable
RevenuePayable
1018000 usd
CY2021Q4 ped Revenue Payable
RevenuePayable
938000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
81000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
114000 usd
CY2022Q4 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
472000 usd
CY2021Q4 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
49000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16962000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5181000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
81000 usd
CY2022Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
2689000 usd
CY2021Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
1476000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
19651000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
6738000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
85790267 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
84236146 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
86000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
84000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
223114000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
220984000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-126741000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-129585000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
96459000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
91483000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
116110000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
98221000 usd
CY2022 us-gaap Revenues
Revenues
30034000 usd
CY2021 us-gaap Revenues
Revenues
15860000 usd
CY2022 us-gaap Lease Cost
LeaseCost
10397000 usd
CY2021 us-gaap Lease Cost
LeaseCost
5943000 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5854000 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6209000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11153000 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7380000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
27404000 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
19532000 usd
CY2022 us-gaap Proceeds From Sale Of Oil And Gas Property And Equipment
ProceedsFromSaleOfOilAndGasPropertyAndEquipment
0 usd
CY2021 us-gaap Proceeds From Sale Of Oil And Gas Property And Equipment
ProceedsFromSaleOfOilAndGasPropertyAndEquipment
1805000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
2630000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-1867000 usd
CY2022 us-gaap Interest Expense
InterestExpense
0 usd
CY2021 us-gaap Interest Expense
InterestExpense
1000 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
117000 usd
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
15000 usd
CY2022 us-gaap Other Income
OtherIncome
97000 usd
CY2021 us-gaap Other Income
OtherIncome
180000 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
374000 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
214000 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
568000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2844000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1299000 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85513095 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79963237 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85513095 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79963237 shares
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2844000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1299000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11153000 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7380000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
2097000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2452000 usd
CY2022 us-gaap Gain Loss On Sale Of Oil And Gas Property
GainLossOnSaleOfOilAndGasProperty
0 usd
CY2021 us-gaap Gain Loss On Sale Of Oil And Gas Property
GainLossOnSaleOfOilAndGasProperty
-1805000 usd
CY2022 ped Increase Decrease On Gains Losses On Extinguishment Of Debt
IncreaseDecreaseOnGainsLossesOnExtinguishmentOfDebt
0 usd
CY2021 ped Increase Decrease On Gains Losses On Extinguishment Of Debt
IncreaseDecreaseOnGainsLossesOnExtinguishmentOfDebt
-374000 usd
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
102000 usd
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
97000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-648000 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1122000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
77000 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-260000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-159000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-356000 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
435000 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1155000 usd
CY2022 ped Increase Decrease Revenue Payable
IncreaseDecreaseRevenuePayable
80000 usd
CY2021 ped Increase Decrease Revenue Payable
IncreaseDecreaseRevenuePayable
102000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15981000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5970000 usd
CY2022 ped Cash Paid For Drilling Costs
CashPaidForDrillingCosts
12252000 usd
CY2021 ped Cash Paid For Drilling Costs
CashPaidForDrillingCosts
4597000 usd
CY2022 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
0 usd
CY2021 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
35000 usd
CY2022 ped Increase Decrease On Proceeds From Sale Of Oil And Gas Property And Equipment
IncreaseDecreaseOnProceedsFromSaleOfOilAndGasPropertyAndEquipment
0 usd
CY2021 ped Increase Decrease On Proceeds From Sale Of Oil And Gas Property And Equipment
IncreaseDecreaseOnProceedsFromSaleOfOilAndGasPropertyAndEquipment
1871000 usd
CY2022 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-14000 usd
CY2021 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
0 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12266000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2761000 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
35000 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14694000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
35000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14694000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3750000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
17903000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29227000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11324000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32977000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29227000 usd
CY2022 us-gaap Interest Paid
InterestPaid
0 usd
CY2021 us-gaap Interest Paid
InterestPaid
0 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 ped Accrued Oil And Gas Development Costs
AccruedOilAndGasDevelopmentCosts
10879000 usd
CY2021 ped Accrued Oil And Gas Development Costs
AccruedOilAndGasDevelopmentCosts
2412000 usd
CY2022 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
618000 usd
CY2021 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
319000 usd
CY2022 ped Issuance Of Restricted Common Stock
IssuanceOfRestrictedCommonStock
2000 usd
CY2021 ped Issuance Of Restricted Common Stock
IssuanceOfRestrictedCommonStock
1000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
75636000 usd
CY2021 ped Restricted Stock Issued During Period Value New Issues
RestrictedStockIssuedDuringPeriodValueNewIssues
0 usd
CY2021 ped Stock Rescinded During Period Value
StockRescindedDuringPeriodValue
0 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
14694000 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
CY2021 ped Stock Based Compensation
StockBasedCompensation
2452000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1299000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
91483000 usd
CY2022 ped Restricted Stock Issued During Period Value New Issues
RestrictedStockIssuedDuringPeriodValueNewIssues
0 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
35000 usd
CY2022 ped Stock Based Compensation
StockBasedCompensation
2097000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2844000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
96459000 usd
CY2021Q4 us-gaap Other Receivables
OtherReceivables
116000 usd
CY2022Q4 ped Cash In An Escrow Account
CashInAnEscrowAccount
50000000 usd
CY2022 ped Share Equivalents Related To Options To Purchase Of Commmon Stock
ShareEquivalentsRelatedToOptionsToPurchaseOfCommmonStock
1407667 shares
CY2022Q4 us-gaap Cash
Cash
29430000 usd
CY2021Q4 us-gaap Cash
Cash
25930000 usd
CY2022Q4 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
3547000 usd
CY2021Q4 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
3297000 usd
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1407667 shares
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
32977000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
29227000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
250000000 usd
CY2022Q4 ped Collateralized Deposit
CollateralizedDeposit
200000000 usd
CY2022Q4 us-gaap Escrow Deposit
EscrowDeposit
50000000 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
30034000 usd
CY2021Q4 us-gaap Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization
151338000 usd
CY2022Q4 us-gaap Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization
176253000 usd
CY2021Q4 ped Oil And Gas Property Successful Effort Method Not Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodNotAccumulatedDepreciationDepletionAndAmortization
2559000 usd
CY2022Q4 ped Oil And Gas Property Successful Effort Method Not Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodNotAccumulatedDepreciationDepletionAndAmortization
775000 usd
CY2021Q4 ped Asset Retirement Costs
AssetRetirementCosts
789 usd
CY2022Q4 ped Asset Retirement Costs
AssetRetirementCosts
1407 usd
CY2021Q4 us-gaap Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion Amortization And Impairment
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAmortizationAndImpairment
88219000 usd
CY2022Q4 us-gaap Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion Amortization And Impairment
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAmortizationAndImpairment
98288000 usd
CY2021Q4 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
66467000 usd
CY2022Q4 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
80147000 usd
CY2020Q4 us-gaap Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization
146950000 usd
CY2020Q4 ped Oil And Gas Property Successful Effort Method Not Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodNotAccumulatedDepreciationDepletionAndAmortization
4000 usd
CY2020Q4 ped Asset Retirement Costs
AssetRetirementCosts
1108 usd
CY2020Q4 us-gaap Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion Amortization And Impairment
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAmortizationAndImpairment
81064000 usd
CY2020Q4 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
66998000 usd
CY2022 ped Capital Costs Incurred Recently Completed Wells
CapitalCostsIncurredRecentlyCompletedWells
23131000 usd
CY2022 ped Acquisition And Development Of Assets
AcquisitionAndDevelopmentOfAssets
8400000 usd
CY2022 ped Capital Cost Of Drilling And Completion
CapitalCostOfDrillingAndCompletion
12500000 usd
CY2021Q3 us-gaap Business Combination Contingent Consideration Asset
BusinessCombinationContingentConsiderationAsset
500000 usd
CY2022Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
1200000 usd
CY2022Q4 us-gaap Acquisition Costs Cumulative
AcquisitionCostsCumulative
607000 usd
CY2022Q4 ped Cost Of Due Deligence
CostOfDueDeligence
688000 usd
CY2021 ped Capital Costs Incurred Recently Completed Wells
CapitalCostsIncurredRecentlyCompletedWells
7009000 usd
CY2021Q4 ped Net Cash Received
NetCashReceived
1900000 usd
CY2022 ped Description Of Additional Paid
DescriptionOfAdditionalPaid
an additional $52,000 paid by Red Hawk in July 2021. As a result of the transaction, the Company recognized a $1.8 million gain on sale of oil and gas properties on the Statement of Operations for the year ended December 31, 2021
CY2021 ped Option Unexercise Expired
OptionUnexerciseExpired
281081 shares
CY2022 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
424000000 usd
CY2021 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
533000000 usd
CY2021 ped Share Equivalents Related To Options To Purchase Of Commmon Stock
ShareEquivalentsRelatedToOptionsToPurchaseOfCommmonStock
1123435 shares
CY2021Q4 ped Loss On Aro
LossOnAro
0 usd
CY2021Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1525000 usd
CY2022 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1060000 usd
CY2022 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
42000 usd
CY2022 ped Changes In Estimates
ChangesInEstimates
618000 usd
CY2022Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
3161000 usd
CY2021Q4 ped Cureent Asset Retirement
CureentAssetRetirement
49000000 usd
CY2022Q4 ped Cureent Asset Retirement
CureentAssetRetirement
472000000 usd
CY2022 us-gaap Other Expenses
OtherExpenses
10000 usd
CY2022 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2027-02-28
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
121000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
71000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
81000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
81000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
82000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
82000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
81000 usd
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85513095 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79963237 shares
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1440000 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1250000 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
16667 shares
CY2021Q1 us-gaap Shares Outstanding
SharesOutstanding
5968500 shares
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.50
CY2021Q1 ped Underwriter Discount Percent
UnderwriterDiscountPercent
0.06 pure
CY2021Q1 ped Net Proceeds
NetProceeds
8200000 usd
CY2021Q4 us-gaap Shares Outstanding
SharesOutstanding
4458600 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.57
CY2021Q4 ped Net Proceeds
NetProceeds
6500000 usd
CY2021Q1 ped Shares Of Restricted Common Stock
SharesOfRestrictedCommonStock
16667 shares
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
1673000 usd
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
1919000 usd
CY2022Q4 ped Unamortized Stock Based Compensation Expense Restricted Stock Option
UnamortizedStockBasedCompensationExpenseRestrictedStockOption
878000 usd
CY2021Q4 ped Unamortized Stock Based Compensation Expense Restricted Stock Option
UnamortizedStockBasedCompensationExpenseRestrictedStockOption
866000 usd
CY2022Q1 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
520000 shares
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.17
CY2022Q1 us-gaap Contract Termination Claims Description
ContractTerminationClaimsDescription
The options have a term of five years and fully vest on January 2025, with 33.3% vesting each subsequent year from the date of grant, contingent upon the recipient’s continued service with the Company
CY2022Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
454000 usd
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Discount For Postvesting Restrictions
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions
0.0156 pure
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y6M
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.20 pure
CY2021Q1 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
550000 shares
CY2021Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.39
CY2021Q1 us-gaap Contract Termination Claims Description
ContractTerminationClaimsDescription
The options have a term of five years and fully vest in January 2024, with 33.3% vesting each subsequent year from the date of grant, contingent upon each recipient’s continued service with the Company
CY2021Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
654000 usd
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Discount For Postvesting Restrictions
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions
0.0045 pure
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y6M
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.56 pure
CY2021Q1 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
86430 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
191999 shares
CY2021Q1 ped Coomon Stock Market Value
CoomonStockMarketValue
2.89
CY2021Q1 ped Aggregate Intrinsic Value Of Options
AggregateIntrinsicValueOfOptions
250000 usd
CY2021Q4 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
52943 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
75000 shares
CY2021Q4 us-gaap Option Indexed To Issuers Equity Strike Price1
OptionIndexedToIssuersEquityStrikePrice1
0.3088
CY2021Q4 ped Coomon Stock Market Value
CoomonStockMarketValue
1.05
CY2021Q4 ped Aggregate Intrinsic Value Of Options
AggregateIntrinsicValueOfOptions
56000 usd
CY2021 ped Option Rescinded
OptionRescinded
113334 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1123435 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.80
CY2022 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1234849 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.43
CY2021 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P2Y8M12D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
520000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.17
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
550000 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.39
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
235768 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.17
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
394415 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
3.57
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
266999 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.23
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1407667 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.51
CY2022 ped Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2a
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2a
P2Y8M12D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1123435 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.80
CY2021 ped Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2a
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2a
P3Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
575667 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.79
CY2022 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P1Y7M6D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
366101 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.42
CY2021 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P1Y8M12D
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2844000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1299000 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85513095 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79963237 shares
CY2022 us-gaap Dilutive Securities
DilutiveSecurities
0 usd
CY2021 us-gaap Dilutive Securities
DilutiveSecurities
0 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0664 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0664 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization
0.0000 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization
0.0000 pure
CY2022 ped Meals And Entertainment
MealsAndEntertainment
0.0002 pure
CY2021 ped Meals And Entertainment
MealsAndEntertainment
-0.0003 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
0.0000 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
0.0795 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Life Insurance
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLifeInsurance
0.0249 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Life Insurance
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLifeInsurance
-0.0573 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.0000 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.0650 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.0000 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.0000 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3015 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3634 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000 pure
CY2022Q4 ped Deferred Tax Assets Tax Accretion
DeferredTaxAssetsTaxAccretion
425000 usd
CY2021Q4 ped Deferred Tax Assets Tax Accretion
DeferredTaxAssetsTaxAccretion
132000 usd
CY2022Q4 ped Deferred Tax Assets Difference In Depreciation Depletion And Capitalization Methods Oil And Natural Gas Properties
DeferredTaxAssetsDifferenceInDepreciationDepletionAndCapitalizationMethodsOilAndNaturalGasProperties
1516000 usd
CY2021Q4 ped Deferred Tax Assets Difference In Depreciation Depletion And Capitalization Methods Oil And Natural Gas Properties
DeferredTaxAssetsDifferenceInDepreciationDepletionAndCapitalizationMethodsOilAndNaturalGasProperties
2389000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
1000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
5343000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
5343000 usd
CY2022Q4 us-gaap Lease Deposit Liability
LeaseDepositLiability
58 usd
CY2021Q4 us-gaap Lease Deposit Liability
LeaseDepositLiability
56 usd
CY2022Q4 ped Rou Assets
RouAssets
80 usd
CY2021Q4 ped Rou Assets
RouAssets
52 usd
CY2022Q4 ped Gain Loss From Sale Of Fa And Or Og Properties
GainLossFromSaleOfFaAndOrOGProperties
-59 usd
CY2021Q4 ped Gain Loss From Sale Of Fa And Or Og Properties
GainLossFromSaleOfFaAndOrOGProperties
0 usd
CY2022Q4 ped Loss On Aro
LossOnAro
23 usd
CY2022Q4 ped Stock Options Nq
StockOptionsNq
-174 usd
CY2021Q4 ped Stock Options Nq
StockOptionsNq
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1507000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1149000 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
24080000 usd
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
24422000 usd
CY2022Q4 ped Net Operating Losses State Taxes
NetOperatingLossesStateTaxes
3423000 usd
CY2021Q4 ped Net Operating Losses State Taxes
NetOperatingLossesStateTaxes
3531000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
36106000 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
39963000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
36106000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
36963000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022 ped Ownership Change Percent
OwnershipChangePercent
0.50 pure
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-858000 usd
CY2022 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P15Y
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
115000000 usd
CY2022 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
93000000 usd
CY2022 ped Not Utilized Amount Expiry
NotUtilizedAmountExpiry
22000000 usd
CY2022 ped Taxable Income Percent
TaxableIncomePercent
0.80 pure
CY2022 dei Auditor Firm
AuditorFirmId
688

Files In Submission

Name View Source Status
0001654954-23-003759-index-headers.html Edgar Link pending
0001654954-23-003759-index.html Edgar Link pending
0001654954-23-003759.txt Edgar Link pending
0001654954-23-003759-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ped-20221231.xsd Edgar Link pending
ped_10k.htm Edgar Link pending
ped_10kimg1.jpg Edgar Link pending
ped_10kimg2.jpg Edgar Link pending
ped_10kimg3.jpg Edgar Link pending
ped_10kimg4.jpg Edgar Link pending
ped_10kimg5.jpg Edgar Link pending
ped_ex211.htm Edgar Link pending
ped_ex231.htm Edgar Link pending
ped_ex232.htm Edgar Link pending
ped_ex232img1.gif Edgar Link pending
ped_ex311.htm Edgar Link pending
ped_ex312.htm Edgar Link pending
ped_ex321.htm Edgar Link pending
ped_ex322.htm Edgar Link pending
ped_ex991.htm Edgar Link pending
ped_ex991img1.jpg Edgar Link pending
ped_ex991img2.jpg Edgar Link pending
ped_ex991img3.jpg Edgar Link pending
ped_ex991img4.jpg Edgar Link pending
ped_ex991img5.jpg Edgar Link pending
ped_ex991img6.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
ped-20221231_cal.xml Edgar Link unprocessable
ped-20221231_def.xml Edgar Link unprocessable
ped-20221231_pre.xml Edgar Link unprocessable
ped-20221231_lab.xml Edgar Link unprocessable
ped_10k_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable